chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse referring to a 17 year old male patient. The patient's concomitant medication, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 04-OCT-2017, the patient was vaccinated with either GARDASIL lot # N000326, expiration date 14-OCT-2019 or GARDASIL 9 lot # N000326, expiration date: not reported (strength, dose, dose number and route of administration were not provided) for prophylaxis which were improperly stored. This is one of several reports received from the same source. Sender's Comments: US-009507513-1709USA008666.
Information has been received from a physician's assistant concerning a 17 year old female who, on an unspecified date, was vaccinated with Gardasil. Three weeks after the vaccination, the patient experienced a miscarriage. The patient was not known to be pregnant at the time the vaccine was administered. The patient was examined in a local emergency room, but no details are available. The patient was examined in the office as follow-up, but no details were provided. Upon internal review, miscarriage was determined to be an other important medical event. Additional information has been requested.
neuropathy; had a bad fall twice; tingling sensations; had really cold toes and fingers; had problems with swallowing; felt dizzy; feels like she would choke.; On her left foot, she said it felt like she stepped on shards of glass and cut her toes.; This is a spontaneous report from a non-contactable consumer (patient). A 70-year-old female patient received bnt162b2 (COMIRNATY; lot/batch number and expiration date not reported) via an unspecified route of administration on Mar2021 as dose 1, single and via an unspecified route of administration on Mar2021 as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient said she received her 1st and 2nd doses last Mar2021. Months after the 1st dose, she said she felt dizzy. She also mentioned that she is currently dizzy, and feels "dizzy to the left." However, she isn't sure whether if it was because of the vaccine or if it was because she's recently had a bad fall twice. A month, 2, or 3 months after her 1st dose (2021), she said she had neuropathy. She had tingling sensations, and had really cold toes and fingers. On her left foot, she said it felt like she stepped on shards of glass and cut her toes. She also said she had problems with swallowing, and feels like she would choke. She wants to know if these were symptoms of the vaccine. Outcome of the event dizzy was not recovered while unknown for the other events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
no adverse event; Monovalent dose administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) in a 50-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patients.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patients.).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.
Pt. is a 58 year old physician with no preexisting medical conditions  Presented for elective vaccination with Zostavax.  Chickenpox as child and one herpetic (presumed) upper lip lesion at age 13.  Subcutaneous injection was painless.  6 hours later, pt. noted erythema with 3 inches of induration at injection site, which was left covered.  Pain and induration persist at 5 days post vaccine. At 48 hours post vaccine, pt. noted onset of viral blister on lower lip involving the mucosa and adjacent skin.  Blister persists at 72 hours post vaccine. There is no warning in the labeling or the store about the potential for outbreaks of Herpes simplex post Zostavax.  However, internet search reveals numerous complaints on bulletin boards and elsewhere regarding this complication.
Took an antibody test twice and it came back as negative; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (Took an antibody test twice and it came back as negative) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced ANTIBODY TEST NEGATIVE (Took an antibody test twice and it came back as negative). At the time of the report, ANTIBODY TEST NEGATIVE (Took an antibody test twice and it came back as negative) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 antibody test: negative (Negative) Took an antibody test twice and it came back as negative..         Concomitant medications included medications for chemotherapy (three different medications) and immunosuppressants.  No treatment information was provided.  Very limited information has been provided for the event at this time. Further information has been requested. However, date of testing the antibodies and the chemo therapy drug details are required for further evaluation.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant followup appended. Patient demographics added.; Sender's Comments: Very limited information has been provided for the event at this time. Further information has been requested. However, date of testing the antibodies and the chemo therapy drug details are required for further evaluation.
Widespread rash. Patient prescribed Prednisone and betamethasone cream 0.05%; consult with dermatology and rheumatology. Symptoms still ongoing.
9-13-16 Redness/swelling started. 9-14-16 Redness, swelling, bruising. 9-15-16 Redness and swelling progressed down arm swelling in shoulder area. 9-16-16 Swelling/redness subsided.
I?m not saying if this is a provable connection or just a coincidence, but my period was about a week late after first dose, which is not a big deal in itself, but months later I am still having cyclical symptoms that I haven?t had since being on birth control years ago: gained a few pounds, bloating/gas starting 7-10 days before period starts, headache day before period starts. I would like to know if there are hormones or hormone mimicers in the vaccine.
urinary tract infection; This is a spontaneous report from a contactable consumer. A (age: 61; unit: unknown) female pa-tient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number & Expiry date not reported) via unspecified route of administration on 14Mar2021 as single dose for Covid-19 Immunization. Patients medical history include menstrual disorder, rheumatoid arthritis. Patient concomitant medications include hydrocortisone acetate (ANUCORT-HC) used for menopause complications in vagina and estradiol (vaginal cream) used for unspecified indication and unknown if ongoing. On 2Apr2021 patient experienced urinary tract infection. It was reported that she has rheumatoid arthritis and gets infusion shots every 6 months of methylprednisolone sodium succinate to 125 mg and rituximab 10 mg and she is due to get them this year. After the verbal response the caller stated she sees her Rheumatologist tomorrow and then has the appointment that day for the infusion so she will ask him before she goes. Additionally, she had a mammogram scheduled on Monday and they told her to cancel that [because she got the shot on Sunday]. She queried if rituximab 10 mg would interact with the vaccine. She had the initial dose on Sunday 14Mar2021 but she has Rheumatoid Arthritis and needs to be infused. Caller is asking if she can cancel the infusion for her to take the 2nd dose. Her address is (address withheld) and her phone number is (phone no. withheld). She queried Getting ready to take 3 medicines, but going to get 2nd shot of Pfizer covid vaccine tomorrow, is there any problem with taking these medications. Bactrim - urinary tract infection (New medication, just got diagnosed today). She queried she is taking Bactrim, is there any contraindication with taking this with the Pfizer covid 19 vaccine. I am taking Bactrim and Estradiol, is there any contraindication with taking this with the Pfizer covid 19 vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Bad pain down leg , swollen leg, very sharp pain that move into foot . foot swells everyday since vaccine
didn't believe they actually put anything in my arm. It's just starting to hurt now; syringe snapped and my arm was sprayed with liquid; syringe snapped and my arm was sprayed with liquid; so not knowing if any at all went in my arm I asked them to redo it. They finally did; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the arm on 19Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The facility where the patient was vaccinated was unknown. It was unknown if the patient received other vaccine in four weeks. The patient's medical history and concomitant medications were not reported. It was reported that the patient received her 2nd Pfizer vaccine today (19Mar2021). Unfortunately, and nothing to do with the vaccine, it didn't go so well. The syringe snapped and her arm was sprayed with liquid, so not knowing if any at all went in her arm she asked them to redo it. They finally did but until a few minutes ago she didn't believe they actually put anything in her arm. It was just starting to hurt now. She thinks with mass vax sites there are a lot of people who are dolling out medical advice and they shouldn't. And in this case today, no one knew what they should actually do. The patient stated "Concerning but hopefully I feel some side effects to know I got some good juice in my arm!". It was unknown if the patient received treatment for the events. It was also unknown if the patient had COVID prior to vaccination and if the patient was tested for COVID post vaccination. The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
patient was nervous/anxious about the shot. Sat in chair and received shot in the left deltoid with no issue. Stood up to leave a minute later and told her mom that she felt dizzy and nauseous. We had her sit back down and she got a little shaky. Face seemed to loose all its color. she said everything went black and she was dizzy. she closed her eyes and laid her head back against the wall. I left the vaccine room to alert my pharmacist and as I walked out the door the patients brother said that she had started shaking like she was having a seizure and she passed out. She was seated and mom was supporting her while we called 911. patient came to within 30 seconds or so and was lethargic and dizzy still. Pharmacist too her blood pressure while waiting on emt and it was 102/52, heart rate 64. emt arrived and took over. emt was with the patient for about 10 minutes then left with her on a stretcher. emt left notes that her vitals while sitting were 93/56, heart rate 66, o2 100%. standing 80/50
pt reported some tenderness in lymph nodes in axillary area w/some swelling;all sx gone on exam;
When attempting to administer vaccine, PHN did insert needle far enough and vaccine leaked out of bevel of needle.  No wheal formed and it is believed that no vaccine was received by pt.  PHN stopped with injection after approximately 1/5th of dose leaked from needle.
I had breakthrough menstrual bleeding while in oral contraceptive pills on the day of my vaccine. I have had two other episodes of breakthrough bleeding while continuing on oral contraceptives on September 14th, October 25th, December 17th
Arm pain; Fever; Injection was not given intramuscularly but rather in a blood vessel; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Injection was not given intramuscularly but rather in a blood vessel) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Systemic) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Injection was not given intramuscularly but rather in a blood vessel). At the time of the report, PAIN IN EXTREMITY (Arm pain) and PYREXIA (Fever) outcome was unknown and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Injection was not given intramuscularly but rather in a blood vessel) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Systemic) was unknown.       No Concomitant medication information was reported. No treatment medications were provided.   Reporter did not allow further contact
intense flu-like symptoms, severe pain in both shoulders, entire left arm felt strange and painful, very large, hard swelling at injection site, very large swelling and lump in arm pit so much so that arm could not rest at side of body comfortably. Heavy nausea, unusual sleepiness, light headedness, sore throat, sometimes needed assistance when walking, loss of appetite. Still feel some residual pain and discomfort at injection site and in armpit. Temperature reached 100.4 at its peak.
pt recv vax 21OCT97 & 12NOV97 pt devel approx 13 lesions;devel a few on back, legs, face, & foot as well as a low grade fever;
COVID-19 breakthrough: I received my 2nd booster shot on 04/11/2022. I started experiencing adverse even on 04/27/2022 in the morning around 8:00AM. I tested positive on the same day, and I also tested every other day. I started with a deep cough, fever, and a headache. I took Paxlovid from 04/27/2022 for 5 days. I contacted my doctor the same day I tested positive, and I started taking the medication on the same night. Its May I still have cough, not as bad as before, but it's getting better.
pt exp bilat patella pain;28OCt & pain when hanging position, unable to knee pain;pain also present in lateral feet & in joint of both hands & rt arm;sore throat & enlarged cervical nodes;fatigue;pruritus on abd w/pink macular spots;rash;
severe pain @ onset, then involved total body; rapid heart beat; breathing difficult @ times; inability to stand straight then to walk w/o assistance; abn quantities of sleep; apathy, weakness; discomfort;
7cm x 7.5cm redness at injection site with slight induration, mild tenderness, warm to touch 9/23 area of induration has increased, slightly less reddened, area warm to touch, antibiotics prescribed for 7 days Keflex.
FULL BODY CONVOLUTIONS, BODY TICKS, STOMACH PAINS, INCREASE IN FOOD SENSITIVITY, SIGNIFICANT HAIR LOSS, FLU LIKE FEELING FIRST COUPLE DAYS, RANDOM PASSING OUT.
Right armpit starting hurting; Noticed lymph nodes swollen; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 28Feb2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies, high blood pressure, type 2 diabetic and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient received unspecified concomitant medications. The patient previously received cefuroxime axetil (CEFTIN) and experienced drug allergy. On 03Mar2021, a couple of days after the shot, the patient's right armpit started hurting and noticed lymph nodes swollen about a week later after the shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right armpit starting hurting and noticed lymph nodes swollen was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Approx. 1 week after the vaccine was administered, patient developed vertical nystagmus and diplopia, imbalance, nausea, dysautonomic symptoms, and gait dysfunction requiring hospitalization. While hospitalized T2 hyperintense white matter lesions concerning for demyelination were noted on MRI of the brain. Patient was treated with IV steroids and symptoms improved enough for d/c to home. Patient continues with neurological deficits requiring outpatient physical and occupational therapy, ambulating with assistive device, cannot drive, and is on long-term disability from work due to visual deficits.
I woke up in the middle of the with an itchy left ear and woke up that morning (4/15)  with severe dizziness. I was completely off balance, nauseous and couldn't stand up straight. I took a Meclizine and laid down. The next two weeks or more I felt very tired and shaky. I felt like something was wrong with me but didn't know what it was. I continued to have fullness in my left ear, and days where I felt off balance. I started to get very off balance again on 4/24 and took medication again. I have continued to feel dizzy and off balance since, on and off. I sometimes wake in the middle of the night and fall to the left side. I experienced dizziness again 5/15 and took Meclizine again.
URI symptoms starting 9/21/21; productive cough, sore throat, headache, shortness of breath, body aches, fever, diarrhea, loss of smell since 01/2020, wheezing, itchy ears.
Itchy rash; Huge swelling around the shot; This spontaneous case was reported by a health care professional and describes the occurrence of RASH PRURITIC (Itchy rash) and VACCINATION SITE SWELLING (Huge swelling around the shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Dec-2021, the patient experienced RASH PRURITIC (Itchy rash) and VACCINATION SITE SWELLING (Huge swelling around the shot). At the time of the report, RASH PRURITIC (Itchy rash) and VACCINATION SITE SWELLING (Huge swelling around the shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided.  No treatment medication was provided.
No additional adverse events reported.; was administered improperly stored during a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On 05-OCT-2021, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(rHA)(PROQUAD), 0.5 milliliter, lot # T034614, expiration date 10-APR-2022 (dose number and route of administration were not reported) for prophylaxis (product storage error).  The vaccine was stored for cumulative time frame of 1 hour and 18 minutes as following: in the temperature of 8.5 degrees Fahrenheit (F) for 18 minutes and in the temperature of 11.9 F for 1 hour. There was no previous temperature excursion.  No additional adverse events were reported (no adverse event).
PATIENT EXPERIENCED DIZZINESS, BLURRY VISION, HEARING LOSS AND BECAME SHAKY AND PALE ABOUT 2 MINUTES AFTER GETTING THE VACCINE. SHE WAS STILL SEATED IN THE IMMUNIZATION ROOM AT THE TIME THE ADVERSE EVENT OCCURED. SHE REMAINED SEATED IN THE ROOM FOR ABOUT 20 MINUTES BEFORE FEELING WELL ENOUGH TO LEAVE. SHE WAS GIVEN WATER AND AN ICE PACK.
LEFT ARM SWOLLEN, REDNESS, WARM TO TOUCH AT SITE OF INJECTION. ITCHING OCCASIONALLY. NO FEVER. LASTED APPROX. 2 DAYS. COLD COMPRESS TO SITE AND TYLENOL.
1PM 31JUL92 recvd Engerix-B & 1-2 hrs later devel a t101, nausea, vomiting, numbness, tingling & swelling of hands; ER or MD visit was required;